Weekly Recap | Zepp Health -16.91%, rallied early and faded late
Weekly Review·
- Zepp Health accumulated a decline of 16.91% this week to close at 2.31 dollars, showing a volatile trend with a weekly amplitude of 32.48%.
- The company released no new financial or business announcements during the week, while current analyst coverage consists of just 1 buy rating with a consensus target price of 43.86 dollars.
- Upcoming focus points include US macroeconomic data releases next week and the 2026 fiscal year annual report scheduled for March 15, 2027.
